531 related articles for article (PubMed ID: 17716196)
1. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
Giri S; Trewyn BG; Lin VS
Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
[TBL] [Abstract][Full Text] [Related]
2. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured mesoporous silica matrices in nanomedicine.
Vallet-Regí M
J Intern Med; 2010 Jan; 267(1):22-43. PubMed ID: 20059642
[TBL] [Abstract][Full Text] [Related]
4. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS
J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine.
Garcia-Bennett AE
Nanomedicine (Lond); 2011 Jul; 6(5):867-77. PubMed ID: 21793677
[TBL] [Abstract][Full Text] [Related]
7. Large pore mesoporous silica nanomaterials for application in delivery of biomolecules.
Knežević NŽ; Durand JO
Nanoscale; 2015 Feb; 7(6):2199-209. PubMed ID: 25583539
[TBL] [Abstract][Full Text] [Related]
8. Functionalized mesoporous silica materials for controlled drug delivery.
Yang P; Gai S; Lin J
Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
[TBL] [Abstract][Full Text] [Related]
9. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
12. High surface area Au-SBA-15 and Au-MCM-41 materials synthesis: tryptophan amino acid mediated confinement of gold nanostructures within the mesoporous silica pore walls.
Selvakannan P; Mantri K; Tardio J; Bhargava SK
J Colloid Interface Sci; 2013 Mar; 394():475-84. PubMed ID: 23351474
[TBL] [Abstract][Full Text] [Related]
13. Dendritic silica nanomaterials (KCC-1) with fibrous pore structure possess high DNA adsorption capacity and effectively deliver genes in vitro.
Huang X; Tao Z; Praskavich JC; Goswami A; Al-Sharab JF; Minko T; Polshettiwar V; Asefa T
Langmuir; 2014 Sep; 30(36):10886-98. PubMed ID: 25188675
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles.
Giri S; Trewyn BG; Stellmaker MP; Lin VS
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5038-44. PubMed ID: 16038000
[No Abstract] [Full Text] [Related]
15. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
[TBL] [Abstract][Full Text] [Related]
16. Use of degradable and nondegradable nanomaterials for controlled release.
Wan WK; Yang L; Padavan DT
Nanomedicine (Lond); 2007 Aug; 2(4):483-509. PubMed ID: 17716133
[TBL] [Abstract][Full Text] [Related]
17. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems.
Trewyn BG; Giri S; Slowing II; Lin VS
Chem Commun (Camb); 2007 Aug; (31):3236-45. PubMed ID: 17668088
[TBL] [Abstract][Full Text] [Related]
19. The development of chiral nematic mesoporous materials.
Kelly JA; Giese M; Shopsowitz KE; Hamad WY; MacLachlan MJ
Acc Chem Res; 2014 Apr; 47(4):1088-96. PubMed ID: 24694253
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery from ordered mesoporous matrices.
Manzano M; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
